A committee-supported project or activity that has been completed and for which output dissemination has begun. Its committee has been disbanded and closeout procedures are underway. A planning ...
AZoLifeSciences on MSN
Data Mining Techniques in High-Throughput Genomics
With high-throughput genomics, scientists can sequence thousands or millions of DNA fragments simultaneously, significantly ...
Illumina Inc. ILMN recently invested in seven new genomics companies that are advancing breakthrough therapeutics, diagnostics, DNA storage, mental wellness, and sustainable foods applications.
BOULDER, Colo.--(BUSINESS WIRE)--Watchmaker Genomics, a supplier of innovative products for molecular analysis, today announced a multi-year, co-exclusive agreement with Exact Sciences Corporation, a ...
SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ ...
A team of scientists report a new method for identifying any genome sequence located next to a known sequence. Sonication Inverse PCR (SIP) can be used to characterize any DNA sequence (near a known ...
Genomics will make the dream of targeted therapies a reality, which will have a massive health and economic impact. Yet most large life science enterprises, from pharma to providers, have yet to fully ...
April 25 marks an annual celebratory occasion for the genomics world: DNA Day. The designation commemorates the remarkable progress the industry has collectively made in our understanding of genomics ...
MediSapiens launches first-in-kind fully integrated and unified cloud computing application that harnesses the power of Big Data and enables knowledge-based drug discovery and repositioning for ...
Watchmaking, at least before the days of digital watches, carries the connotation of precision engineering and complex assembly by a craftsman, an analogy that extends to the development of next-gen ...
Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path for Blood Disorder Diagnosis, complementing bone marrow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback